Episode 263: Lifestyle, Longevity, and the Future of GLP-1 Agonist Use in Wellness with Christa Rymal
Join me, Dr. Mike T Nelson, as we explore the fascinating world of GLP-1 agonists like Wegovy with diabetes education expert Christa Rymal. We discuss the nuances of these weight loss drugs, their benefits, and potential drawbacks, especially in relation to diabetes management and off-label uses.
Christa's insights provide a deeper understanding of how these medications work beyond glucose control, their impact on appetite, and the critical need for monitoring in prescribed use. We also contemplate the future of health and wellness models that might integrate these drugs and the significant role fitness professionals can play in this evolving landscape.
Sponsors:
Episode Chapters:
Episodes You May Enjoy:
Find Christa:
Get In Touch:
Create your
podcast in
minutes
It is Free